KR20040030161A - 인간 배 줄기 세포(ｈＥＳＣ)주를 확립하기 위한 내부세포 덩어리의 분리 방법 - Google Patents
인간 배 줄기 세포(ｈＥＳＣ)주를 확립하기 위한 내부세포 덩어리의 분리 방법 Download PDFInfo
- Publication number
- KR20040030161A KR20040030161A KR10-2004-7002520A KR20047002520A KR20040030161A KR 20040030161 A KR20040030161 A KR 20040030161A KR 20047002520 A KR20047002520 A KR 20047002520A KR 20040030161 A KR20040030161 A KR 20040030161A
- Authority
- KR
- South Korea
- Prior art keywords
- cell mass
- embryonic stem
- icm
- medium
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 156
- 210000001671 embryonic stem cell Anatomy 0.000 title claims abstract description 39
- 238000002955 isolation Methods 0.000 title description 8
- 210000004340 zona pellucida Anatomy 0.000 claims abstract description 33
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 31
- 230000001228 trophic effect Effects 0.000 claims abstract description 22
- 238000000608 laser ablation Methods 0.000 claims abstract description 15
- 230000003325 follicular Effects 0.000 claims abstract description 4
- 239000011148 porous material Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 67
- 239000002609 medium Substances 0.000 claims description 32
- 238000001000 micrograph Methods 0.000 claims description 20
- 241001465754 Metazoa Species 0.000 claims description 13
- 238000001574 biopsy Methods 0.000 claims description 11
- 210000002950 fibroblast Anatomy 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 7
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 239000002480 mineral oil Substances 0.000 claims description 4
- 235000010446 mineral oil Nutrition 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000003797 essential amino acid Substances 0.000 claims description 3
- 235000020776 essential amino acid Nutrition 0.000 claims description 3
- 239000012091 fetal bovine serum Substances 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229940054269 sodium pyruvate Drugs 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 210000002993 trophoblast Anatomy 0.000 claims description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 2
- 229930182816 L-glutamine Natural products 0.000 claims 2
- 229940126864 fibroblast growth factor Drugs 0.000 claims 2
- 241001529936 Murinae Species 0.000 claims 1
- 230000006037 cell lysis Effects 0.000 claims 1
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 238000011536 re-plating Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 210000002257 embryonic structure Anatomy 0.000 abstract description 23
- 230000008569 process Effects 0.000 description 24
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 238000000926 separation method Methods 0.000 description 13
- 210000000130 stem cell Anatomy 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 8
- 230000012447 hatching Effects 0.000 description 8
- 238000003744 In vitro fertilisation Methods 0.000 description 7
- 241000220324 Pyrus Species 0.000 description 7
- 210000000287 oocyte Anatomy 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000004720 fertilization Effects 0.000 description 6
- 208000012404 paroxysmal familial ventricular fibrillation Diseases 0.000 description 6
- 235000014443 Pyrus communis Nutrition 0.000 description 5
- 230000001054 cortical effect Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002611 ovarian Effects 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 238000002679 ablation Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002406 microsurgery Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010057021 Menotropins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010059712 Pronase Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- MQOMKCIKNDDXEZ-UHFFFAOYSA-N 1-dibutylphosphoryloxy-4-nitrobenzene Chemical compound CCCCP(=O)(CCCC)OC1=CC=C([N+]([O-])=O)C=C1 MQOMKCIKNDDXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101000713211 Colocasia esculenta Mannose-specific lectin TAR1 Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 108010006578 follitropin alfa Proteins 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 101150108262 gnrh1 gene Proteins 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940057854 gonal f Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000001722 neurochemical effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
- A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Surgery (AREA)
- Reproductive Health (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Electromagnetism (AREA)
- Optics & Photonics (AREA)
- Transplantation (AREA)
- Pregnancy & Childbirth (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31432301P | 2001-08-23 | 2001-08-23 | |
| US60/314,323 | 2001-08-23 | ||
| PCT/IN2002/000168 WO2003018783A1 (en) | 2001-08-23 | 2002-08-20 | ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20040030161A true KR20040030161A (ko) | 2004-04-08 |
Family
ID=23219502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-2004-7002520A Ceased KR20040030161A (ko) | 2001-08-23 | 2002-08-20 | 인간 배 줄기 세포(ｈＥＳＣ)주를 확립하기 위한 내부세포 덩어리의 분리 방법 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7294508B2 (https=) |
| EP (1) | EP1421181A1 (https=) |
| JP (3) | JP2005514004A (https=) |
| KR (1) | KR20040030161A (https=) |
| CN (1) | CN1545549A (https=) |
| AU (1) | AU2002334378B2 (https=) |
| BR (1) | BR0212098A (https=) |
| CA (1) | CA2458362A1 (https=) |
| IL (2) | IL160351A0 (https=) |
| RU (1) | RU2291703C2 (https=) |
| SG (1) | SG172471A1 (https=) |
| WO (1) | WO2003018783A1 (https=) |
| ZA (1) | ZA200304132B (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030134422A1 (en) * | 2002-01-16 | 2003-07-17 | Sayre Chauncey Bigelow | Stem cell maturation for all tissue lines |
| US20050090004A1 (en) * | 2003-01-16 | 2005-04-28 | Sayre Chauncey B. | Stem cell maturation for all tissue lines |
| US20050170506A1 (en) * | 2002-01-16 | 2005-08-04 | Primegen Biotech Llc | Therapeutic reprogramming, hybrid stem cells and maturation |
| WO2004081172A2 (en) * | 2003-03-12 | 2004-09-23 | Reliance Life Sciences Pvt. Ltd. | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| US7820439B2 (en) * | 2003-09-03 | 2010-10-26 | Reliance Life Sciences Pvt Ltd. | In vitro generation of GABAergic neurons from pluripotent stem cells |
| US20050272149A1 (en) | 2004-06-02 | 2005-12-08 | Life & Brain Gmbh | Therapeutic delivery of adenosine into a tissue |
| DE102004062184B4 (de) | 2004-12-23 | 2013-08-01 | Wolfgang Würfel | Embryonenerhaltende Gewinnung pluripotenter embryonaler Stammzellen, derart gewonnene Stammzellen und Verwendung derselben |
| WO2006091766A2 (en) | 2005-02-24 | 2006-08-31 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
| US7811817B2 (en) | 2005-05-17 | 2010-10-12 | Reliance Life Sciences Pvt. Ltd. | Establishment of a human embryonic stem cell line using mammalian cells |
| US20060269985A1 (en) * | 2005-05-31 | 2006-11-30 | Yasuhiko Kitayama | Method for constructing array blocks, and tissue punching instrument and tissue blocks used therefor |
| KR20160116024A (ko) | 2005-06-22 | 2016-10-06 | 아스테리아스 바이오세라퓨틱스, 인크. | 인간 배아 줄기 세포의 현탁 배양 |
| EP1945758A2 (en) * | 2005-10-07 | 2008-07-23 | Cellartis AB | A method for obtaining a xeno-free hbs cell line |
| WO2007079533A1 (en) * | 2006-01-10 | 2007-07-19 | South Eastern Sydney And Illawarra Area Health Service | Method for establishing and proliferating human esc by co-culturing with allogeneic feeder cells in serum-free media |
| EP2245141B1 (en) | 2008-01-18 | 2018-03-14 | Regents of the University of Minnesota | Stem cell aggregates and methods for making and using |
| WO2010114193A1 (ko) | 2009-03-29 | 2010-10-07 | Kim Chang-Hyun | 내부 세포 덩어리의 분리 방법 및 이를 이용한 배아 줄기 세포주의 제조 방법 |
| SG178064A1 (en) | 2009-07-21 | 2012-03-29 | Abt Holding Co | Use of stem cells to reduce leukocyte extravasation |
| EP2456860B1 (en) | 2009-07-21 | 2018-09-05 | ABT Holding Company | Use of stem cells to reduce leukocyte extravasation |
| JP5115762B2 (ja) * | 2010-02-12 | 2013-01-09 | 有機合成薬品工業株式会社 | ４−ホルミルピペリジンアセタール誘導体の製造方法 |
| WO2011106521A1 (en) | 2010-02-25 | 2011-09-01 | Abt Holding Company | Modulation of macrophage activation |
| SG10201501353YA (en) | 2010-02-25 | 2015-04-29 | Abt Holding Co | Modulation of angiogenesis |
| WO2011143415A1 (en) | 2010-05-12 | 2011-11-17 | Abt Holding Company | Modulation of splenocytes in cell therapy |
| US9090878B2 (en) | 2010-06-17 | 2015-07-28 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
| EP2596119B8 (en) | 2010-07-23 | 2021-06-02 | Astellas Institute for Regenerative Medicine | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| EP2609191B1 (en) | 2010-08-24 | 2017-11-22 | Regents Of The University Of Minnesota | Non-static suspension culture of cell aggregates |
| EP2625264B1 (en) | 2010-10-08 | 2022-12-07 | Terumo BCT, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| WO2012068170A2 (en) | 2010-11-15 | 2012-05-24 | Jau-Nan Lee | Generation of neural stem cells from human trophoblast stem cells |
| US8748178B2 (en) | 2010-11-23 | 2014-06-10 | The New York Stem Cell Foundation | Method for producing pluripotent stem cells |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| EP2718416B1 (en) | 2011-06-06 | 2019-11-13 | Regenesys bvba | Expansion of stem cells in hollow fiber bioreactors |
| GB201119335D0 (en) | 2011-11-09 | 2011-12-21 | Univ Leuven Kath | Hepatitis virus infectable stem cells |
| CN102600507B (zh) * | 2012-03-08 | 2014-08-20 | 天津大学 | 一种细胞培养支架材料及其制备方法 |
| CN113604423B (zh) | 2012-11-30 | 2025-06-03 | 艾克塞利瑞提德生物技术公司 | 通过调节mir-124分化干细胞的方法 |
| JP6666240B2 (ja) | 2013-04-12 | 2020-03-13 | フランチェスカ， サベリオ ラ | 移植のための臓器の改良 |
| DK2992088T3 (da) | 2013-04-30 | 2019-11-11 | Univ Leuven Kath | Celleterapi for myelodysplastiske syndromer |
| JP6633522B2 (ja) | 2013-11-16 | 2020-01-22 | テルモ ビーシーティー、インコーポレーテッド | バイオリアクターにおける細胞増殖 |
| US10202598B2 (en) | 2014-05-30 | 2019-02-12 | Todd Frank Ovokaitys | Methods and systems for generation, use, and delivery of activated stem cells |
| AU2015266594A1 (en) | 2014-05-30 | 2017-01-19 | Todd Frank OVOKAITYS | Method and system for generation and use of activated stem cells |
| US10384985B2 (en) | 2014-06-06 | 2019-08-20 | B.K. Consultants, Inc. | Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants |
| US10040728B2 (en) | 2014-06-06 | 2018-08-07 | Todd Frank Ovokaitys | Methods and compositions for increasing the bioactivity of nutrients |
| SG10202009095VA (en) | 2014-11-26 | 2020-10-29 | Accelerated Biosciences Corp | Induced hepatocytes and uses thereof |
| CN104982419B (zh) * | 2015-07-29 | 2017-01-11 | 广西壮族自治区水牛研究所 | 一种结合激光破膜的水牛胚胎冷冻方法 |
| WO2017210537A1 (en) | 2016-06-02 | 2017-12-07 | The Cleveland Clinic Foundation | Complement inhibition for improving cell viability |
| AU2020268341B2 (en) | 2019-05-06 | 2024-12-12 | Accelerated Biosciences Corp. | Precursory regulatory cytotrophoblast cells and uses thereof |
| WO2022126109A1 (en) | 2020-12-08 | 2022-06-16 | Ovokaitys Todd Frank | Methods and systems for increased production of stem cells |
| US20240219706A1 (en) * | 2021-04-27 | 2024-07-04 | The Governing Council Of University Of Toronto | Systems and Methods for Detection and 3D Imaging of Cell Junctions of Blastocysts and Other Biological Structures |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015671A (en) * | 1995-06-07 | 2000-01-18 | Indiana University Foundation | Myocardial grafts and cellular compositions |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5945577A (en) * | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| WO2000027995A1 (en) * | 1998-11-09 | 2000-05-18 | Monash University | Embryonic stem cells |
| CA2403000C (en) | 2000-03-14 | 2015-06-23 | Es Cell International Pte Ltd | Embryonic stem cells and neural progenitor cells derived therefrom |
-
2002
- 2002-08-20 CA CA002458362A patent/CA2458362A1/en not_active Abandoned
- 2002-08-20 BR BR0212098-4A patent/BR0212098A/pt not_active Application Discontinuation
- 2002-08-20 AU AU2002334378A patent/AU2002334378B2/en not_active Ceased
- 2002-08-20 WO PCT/IN2002/000168 patent/WO2003018783A1/en not_active Ceased
- 2002-08-20 EP EP02796348A patent/EP1421181A1/en not_active Withdrawn
- 2002-08-20 RU RU2004108209/15A patent/RU2291703C2/ru not_active IP Right Cessation
- 2002-08-20 SG SG2006043418A patent/SG172471A1/en unknown
- 2002-08-20 KR KR10-2004-7002520A patent/KR20040030161A/ko not_active Ceased
- 2002-08-20 IL IL16035102A patent/IL160351A0/xx unknown
- 2002-08-20 JP JP2003523634A patent/JP2005514004A/ja active Pending
- 2002-08-20 CN CNA028164210A patent/CN1545549A/zh active Pending
- 2002-08-23 US US10/226,711 patent/US7294508B2/en not_active Expired - Fee Related
-
2003
- 2003-05-28 ZA ZA200304132A patent/ZA200304132B/en unknown
-
2004
- 2004-02-12 IL IL160351A patent/IL160351A/en not_active IP Right Cessation
-
2007
- 2007-11-13 US US11/939,397 patent/US20080064099A1/en not_active Abandoned
- 2007-11-30 JP JP2007311763A patent/JP2008099706A/ja active Pending
-
2008
- 2008-04-25 JP JP2008115762A patent/JP2008194055A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US7294508B2 (en) | 2007-11-13 |
| WO2003018783A1 (en) | 2003-03-06 |
| AU2002334378B2 (en) | 2008-02-28 |
| IL160351A (en) | 2009-11-18 |
| IL160351A0 (en) | 2004-07-25 |
| BR0212098A (pt) | 2004-08-03 |
| US20080064099A1 (en) | 2008-03-13 |
| SG172471A1 (en) | 2011-07-28 |
| CN1545549A (zh) | 2004-11-10 |
| US20030104616A1 (en) | 2003-06-05 |
| JP2008194055A (ja) | 2008-08-28 |
| JP2008099706A (ja) | 2008-05-01 |
| JP2005514004A (ja) | 2005-05-19 |
| RU2004108209A (ru) | 2005-04-20 |
| RU2291703C2 (ru) | 2007-01-20 |
| US20070048864A2 (en) | 2007-03-01 |
| CA2458362A1 (en) | 2003-03-06 |
| ZA200304132B (en) | 2004-07-19 |
| EP1421181A1 (en) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040030161A (ko) | 인간 배 줄기 세포(ｈＥＳＣ)주를 확립하기 위한 내부세포 덩어리의 분리 방법 | |
| AU2002334378A1 (en) | Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines | |
| Fishel et al. | Subzonal insemination for the alleviation of infertility | |
| Silber et al. | High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy | |
| Stein et al. | Assisted hatching by partial zona dissection of human pre-embryos in patients with recurrent implantation failure after in vitro fertilization | |
| Yang et al. | Intracytoplasmic sperm injection improving embryo quality: comparison of the sibling oocytes of non-male-factor couples | |
| Rawlins et al. | Microsurgical enucleation of tripronuclear human zygotes | |
| Ebner et al. | Successful birth after laser assisted immobilization of spermatozoa before intracytoplasmic injection | |
| Nagy et al. | Novel use of laser to assist ICSI for patients with fragile oocytes: a case report | |
| US6132952A (en) | Storage system comprising an emptied zona pellucida and spermatozoa placed therein and a method of cryopreservation | |
| US7083977B2 (en) | Monkey-origin embryonic stem cells | |
| Suppinyopong et al. | Correlation of oocyte morphology with fertilization rate and embryo quality after intracytoplasmic sperm injection | |
| Cohen et al. | Micromanipulation in clinical management of fertility disorders | |
| Ma et al. | Assessment of maximal fertilization rates with intracytoplasmic sperm injection | |
| US6759244B2 (en) | Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos | |
| Anderson et al. | Fertilization, embryonic development and pregnancy losses with intracytoplasmic sperm injection for surgically-retrieved spermatozoa | |
| JP5014535B2 (ja) | カニクイザル由来胚性幹細胞 | |
| Yamamoto et al. | Epididymal sperm retrieval by epididymal micropuncture combined with intracytoplasmic sperm injection: difference between acquired and congenital irreparable obstructive azoospermia | |
| Cohen et al. | Gamete and embryo micromanipulation for infertility treatment | |
| Yamamoto et al. | Microsurgical epididymal sperm aspiration versus epididymal micropuncture with perivascular nerve stimulation for intracytoplasmic sperm injection to treat unreconstructable obstructive azoospermia | |
| Chang et al. | Assisted reproductive technology in nonhuman primates | |
| Palermo et al. | ICSI: technical aspects | |
| Esterhuizen et al. | Micromanipulation at an infertility centre | |
| Park et al. | Comparative results of embryo development and clinical pregnancy using sperm retrieved from fresh and frozen-thawed testicular tissue from patients with obstructive and non-obstructive azoospermia | |
| Edwards | Changing genetic world of IVF, stem cells and PGD. A. Early methods in research |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20040220 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| AMND | Amendment | ||
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20050321 Comment text: Request for Examination of Application |
|
| AMND | Amendment | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060725 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070126 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070731 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20070126 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20060725 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20070830 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20070731 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20080826 Appeal identifier: 2007101009336 Request date: 20070830 |
|
| AMND | Amendment | ||
| PB0901 | Examination by re-examination before a trial |
Comment text: Amendment to Specification, etc. Patent event date: 20070928 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20070830 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20070307 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 20060925 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 20050921 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 20040225 Patent event code: PB09011R02I |
|
| B601 | Maintenance of original decision after re-examination before a trial | ||
| E801 | Decision on dismissal of amendment | ||
| PB0601 | Maintenance of original decision after re-examination before a trial |
Comment text: Report of Result of Re-examination before a Trial Patent event code: PB06011S01D Patent event date: 20071108 |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20071108 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20070928 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20070307 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20060925 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20050921 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20040225 |
|
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070830 Effective date: 20080826 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20080826 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 20070830 Decision date: 20080826 Appeal identifier: 2007101009336 |